Dermatologic and Ophthalmic Drugs Advisory Committee

Results: 196



#Item
71U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
72U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
73SESSION 1:  NDA[removed]Bepotastine Besilate Ophthalmic Solution, 1

SESSION 1: NDA[removed]Bepotastine Besilate Ophthalmic Solution, 1

Add to Reading List

Source URL: www.fda.gov

Language: English
74Quick Minutes (Confidential -  Not to be Released Outside of the Agency)

Quick Minutes (Confidential - Not to be Released Outside of the Agency)

Add to Reading List

Source URL: www.fda.gov

Language: English
75FOOD AND DRUG ADMINISTRATION (FDA)

FOOD AND DRUG ADMINISTRATION (FDA)

Add to Reading List

Source URL: www.fda.gov

Language: English
76[removed]Federal Register / Vol. 69, No[removed]Tuesday, August 31, [removed]Notices Research Working With Stakeholders on Scientific Opportunities for Facilitating

[removed]Federal Register / Vol. 69, No[removed]Tuesday, August 31, [removed]Notices Research Working With Stakeholders on Scientific Opportunities for Facilitating

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-08-31 08:53:41
77FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee Meeting The Great Room, White Oak Conference Center, Food and Drug Administ

FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee Meeting The Great Room, White Oak Conference Center, Food and Drug Administ

Add to Reading List

Source URL: www.fda.gov

Language: English
78U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

Add to Reading List

Source URL: www.fda.gov

Language: English
79ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

Add to Reading List

Source URL: www.fda.gov

Language: English
80ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

Add to Reading List

Source URL: www.fda.gov

Language: English